Navigation Links
BiOptix Continues Support of Antibody Engineering & Therapeutics Research
Date:12/11/2013

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Dec. 11, 2013 /PRNewswire/ -- BiOptix continues support of the global antibody engineering and therapeutics research community through participation in IBC's 24th Annual Antibody Engineering & Therapeutics Conference and annual meeting of The Antibody Society, being held in Huntington Beach, CA from December 8 – 12, 2013.   During the event, BiOptix will be highlighting the BiOptix Innovators Program, a unique and innovative product evaluation platform that allows customers to try BiOptix SPR technology independently in their lab, on their timeframe and with complete customer and technical support during the process. 

While presenting new antibody kinetics data from BiOptix, Ken Wilczek, Vice President, Sales & Marketing for BiOptix noted: "Antibody research and therapeutics continues to be a vital and growing market worldwide—and is a perfect match for the BiOptix 404pi."  "With a unique platform, multiple sensor chemistries and an industry -leading instrumentation demo initiative known as the BiOptix Innovators Program, BiOptix is becoming a principal choice for antibody researchers who require robust and repeatable kinetics."  Additional details about the BiOptix Innovators Program, in which BiOptix seeks to partner with academic, pharmaceutical and biotechnology/drug discovery research labs can be found at:  http://www.bioptix.com/products/innovators-program

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic
'/>"/>

SOURCE BiOptix
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BiOptix continues support of Colorado-based research institutions
2. Celebrating 65 Years of Providing Superior Healthcare Products, Mission Pharmacal Continues to Thrive
3. UV Flu Technologies Continues Aggressive Program to Pay off Convertible Debt
4. AMPAC Fine Chemicals Continues to Invest in Quality Systems
5. Profil Institute Continues to Publish New Findings in Metabolic Research
6. China Cord Blood Corporation Continues Share Repurchase Program
7. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
8. BioStorage Technologies Continues Global Growth; Announces Strategic Expansion Into Asia Pacific and New General Manager APAC
9. Green Coffee Extract Continues Dominance Amongst Summers Top Weight Loss Products
10. Z Trim Holdings Sales Growth Continues in July 2012
11. Z Trim Holdings Sales Growth Continues in August 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... (PRWEB) October 22, 2014 According ... Market by Service Type (Consulting, Integration, Deployment & ... by Deployment Model (Public, Private, Others (Hybrid & ... MarketsandMarkets, defines and segments the Cloud Professional Services ... and forecasting of revenues. It also identifies the ...
(Date:10/22/2014)... and HONG KONG , Oct. 22, ... therapeutics enterprise, announced today that rare disease expert ... vice president, research. Dr. McKew brings more than two ... positions at the National Institutes of Health, Wyeth Research ... Wyeth). Dr. McKew will lead aTyr,s efforts to expand and ...
(Date:10/20/2014)... , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million which brings Q3 orders to $5.8 million and provides a ... projects in North America and one in ... to bid new projects at record levels," said Peter Bruijns ... higher at the end of Q3 than they have been for ...
(Date:10/20/2014)... Earle Martin , Chief Executive ... Ellen Teplitzky, an experienced attorney specializing in business ... has joined the firm as Director of Legal ... NDA Partners provides legal services, including research, ... top law firms and their clients in cases ...
Breaking Biology Technology:Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... (NYSE: DGX ), the world,s leading provider ... for the fourth quarter ended December 31, 2011, adjusted ... per diluted share, compared to $179 million, or $1.03 ... of 2011, reported income from continuing operations was $190 ...
... Lieber, the Mark Hyman Jr. Professor of Chemistry, ... A pioneer in the synthesis of a wide ... unique physical properties of those materials, and the ... Lieber has demonstrated the use of nanoscale materials ...
...  A recent Van Andel Research Institute (VARI) study published in ... function of an essential plant hormone could profoundly change our ... to the development of new drugs for a variety of ... by the same team of investigators at VARI that was ...
Cached Biology Technology:Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 2Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 3Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 4Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 5Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 6Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 7Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 8Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 9Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 10Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 11Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 12Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 13Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 14Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 15Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 16Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 17Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 18Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 19Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 20Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 21Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 22Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 23Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 24Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 25Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 26Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 27Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012 28Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process 2
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2
... help scientists "build" new biological systems, Princeton University scientists ... enable the growth of living cells. The team ... nature, and the scientists showed that they can produce ... as proteins produced by nature,s own toolkit. ...
... ATHENS, Ohio (Jan. 6, 2011) Ohio University ... the bioengineering profession,s highest honor, the Fritz J. and ... Hood of Seattle, Washington, for his discoveries related to ... president and co-founder of the Institute for Systems Biology, ...
... at the University of Connecticut Health Center have identified a ... a predictor of heart attack. Their research, led by ... Cardiology Center, is published in the Jan. 11 issue of ... It found heart attack patients had elevated levels of the ...
Cached Biology News:Princeton scientists construct synthetic proteins that sustain life 2Princeton scientists construct synthetic proteins that sustain life 3DNA sequencing pioneer receives 2011 Russ Prize 2DNA sequencing pioneer receives 2011 Russ Prize 3
Biotin d anti-mouse Tim-1...
Mouse monoclonal [1-N-14] to Adenovirus Type 7 hexon C11 Immunogen: Purified Adenovirus type 7 Specificity: This antibody is specific for Adenovirus type 7 hexon C11....
Request Info...
... is the main excitatory neurotransmitter in the ... considered to act only on the ligand-gated ... that are involved in the fast excitatory ... to regulate enzymes producing second messengers via ...
Biology Products: